在罕见的巨型肺瘤中延迟的新辅助治疗反应:一个病例报告
Kai Zhang1, Yuanyuan Wang2, Yi Li1
1Department of Oncology, 920th Hospital of Joint Logistics Support Force, Kunming, China.
Respiratory medicine case reports
|August 5, 2025
概括
初级肺突肉瘤 (PPSS) 是罕见的,缺乏治疗指南. 一个案例研究表明,新辅助化疗与阿德里亚米辛,伊福斯法米德和安洛替尼在治疗这种具有挑战性的胸内瘤方面表现出有效性.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 医学瘤学 医学瘤学
背景情况:
- 初级肺突肉瘤 (PPSS) 是一种极为罕见的胸内软组织肉瘤.
- 对于PPSS的诊断和治疗,确立的共识指南显著缺乏.
- 这种罕见性给有效的患者管理和临床决策带来了挑战.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


